Site Under Construction
Thank you for your interest in Anuncia, Inc. and our technologies. Please check back with us in a few weeks for our new look and the exciting developments fueling our mission to help patients with Cerebral Spinal Fluid (CSF) Disorders like Hydrocephalus. We look forward to reconnecting soon.
In the interim, we are pleased to announce:
FDA "Breakthrough Device Designation" for ReFlow™ System Mini
If you are a clinician or investor, please contact info@anuncia.com or call (978) 942-5600 for more information. If you are a patient, please contact your clinician. You may find more information on the Hydrocephalus Association website and other patient advocacy group organizations.
© 2021 Anuncia.
All rights reserved. The current ReFlow System is FDA cleared and CE Marked for use by a qualified clinician to facilitate a safe, noninvasive retrograde fluid flush when ventriculoperitoneal shunt flow is restricted or blocked. The ReFlow System Mini is under development and not available for sale. The ReFlow System is a prescription device sold by or on the order of a physician.
